Home
Click and hold a term momentarily to select items without that term.
file_sets.@id
/analysis-sets/IGVFDS0021NCLH/
20 items
  • InVitroSystem
    IGVFSM9186YAGZ
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Bottom 20-40% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM9172BOGO
    HepG2 cell line, male, Homo sapiens modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM7036PBYG
    HepG2 cell line, male, Homo sapiens modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM0239RDRJ
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Bottom 20% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM4480HBZE
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Top 20-40% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM2152OUKV
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Bottom 20-40% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM6216RCYU
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Bottom 20-40% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM5703OIDJ
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Top 20% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM3582GWYM
    HepG2 cell line, male, Homo sapiens modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM5236JKXQ
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Top 20-40% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM3663WDFF
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Top 20-40% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM8157SSTV
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Top 20% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM2673GFKF
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Bottom 20% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM3624LDJK
    HepG2 cell line, male, Homo sapiens modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM1124PLAC
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Bottom 20-40% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM5253OWUJ
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Bottom 20% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM2094QGWS
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Top 20% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM6863YJUL
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Bottom 20% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM9896ADOJ
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Top 20% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released
  • InVitroSystem
    IGVFSM3657JJTM
    HepG2 cell line, male, Homo sapiens (sorting details: Sorted for Top 20-40% LDL-C uptake) modified with CRISPR base editing SpRY-ABE8e, transduced (lentivirus) with a guide library (MOI of 0.5)
    Richard Sherwood, Brigham and Women's Hospital
    released